Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Physical exercises and weight loss in obese patients help to improve uric acid.

Zhou J, Wang Y, Lian F, Chen D, Qiu Q, Xu H, Liang L, Yang X.

Oncotarget. 2017 Oct 25;8(55):94893-94899. doi: 10.18632/oncotarget.22046. eCollection 2017 Nov 7.

2.

Efficacy of Fenugreek-based bionanocomposite on renal dysfunction and endogenous intoxication in high-calorie diet-induced obesity rat model-comparative study.

Konopelniuk VV, Goloborodko II, Ishchuk TV, Synelnyk TB, Ostapchenko LI, Spivak MY, Bubnov RV.

EPMA J. 2017 Jun 16;8(4):377-390. doi: 10.1007/s13167-017-0098-2. eCollection 2017 Dec.

3.

Pegloticase in gout treatment - safety issues, latest evidence and clinical considerations.

Guttmann A, Krasnokutsky S, Pillinger MH, Berhanu A.

Ther Adv Drug Saf. 2017 Dec;8(12):379-388. doi: 10.1177/2042098617727714. Epub 2017 Sep 13. Review.

4.

Determination of lesinurad in rat plasma by a UHPLC-MS/MS assay.

Zhou XY, Yuan LJ, Chen Z, Tang PF, Li XY, Hu GX, Cai JP.

Chem Cent J. 2017 Nov 28;11(1):121. doi: 10.1186/s13065-017-0353-6.

5.

Serum Uric Acid Is Associated with Poor Outcome in Black Africans in the Acute Phase of Stroke.

Mapoure YN, Ayeah CM, Doualla MS, Ba H, Ngahane HBM, Mbahe S, Luma HN.

Stroke Res Treat. 2017;2017:1935136. doi: 10.1155/2017/1935136. Epub 2017 Sep 10.

6.

Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat.

Sheer R, Null KD, Szymanski KA, Sudharshan L, Banovic J, Pasquale MK.

Clinicoecon Outcomes Res. 2017 Oct 10;9:629-639. doi: 10.2147/CEOR.S139939. eCollection 2017.

7.

Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study.

Singh JA, Ramachandaran R, Yu S, Yang S, Xie F, Yun H, Zhang J, Curtis JR.

Arthritis Res Ther. 2017 Oct 17;19(1):228. doi: 10.1186/s13075-017-1427-5.

8.

Microwave Heating of Crystals with Gold Nanoparticles and Synovial Fluid under Synthetic Skin Patches.

McLemore GL, Toker S, Boone-Kukoyi Z, Ajifa H, Lansiquot C, Nwawulu C, Onyedum S, Kioko BM, Aslan K.

ACS Omega. 2017 Sep 30;2(9):5992-6002. doi: 10.1021/acsomega.7b00816. Epub 2017 Sep 20.

9.

The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice.

Reber LL, Starkl P, Balbino B, Sibilano R, Gaudenzio N, Rogalla S, Sensarn S, Kang D, Raghu H, Sokolove J, Robinson WH, Contag CH, Tsai M, Galli SJ.

PLoS One. 2017 Oct 5;12(10):e0185704. doi: 10.1371/journal.pone.0185704. eCollection 2017.

10.

Uric Acid for Cardiovascular Risk: Dr. Jekyll or Mr. Hide?

Vassalle C, Mazzone A, Sabatino L, Carpeggiani C.

Diseases. 2016 Feb 26;4(1). pii: E12. doi: 10.3390/diseases4010012. Review.

11.

Gout and comorbidity: a nominal group study of people with gout.

Singh JA.

Arthritis Res Ther. 2017 Sep 15;19(1):204. doi: 10.1186/s13075-017-1416-8.

12.

A comprehensive analysis of the association of common variants of ABCG2 with gout.

Yu KH, Chang PY, Chang SC, Wu-Chou YH, Wu LA, Chen DP, Lo FS, Lu JJ.

Sci Rep. 2017 Aug 30;7(1):9988. doi: 10.1038/s41598-017-10196-2.

13.

Prevalence of hyperuricemia and its related risk factors among preschool children from China.

Li N, Zhang S, Li W, Wang L, Liu H, Li W, Zhang T, Liu G, Du Y, Leng J.

Sci Rep. 2017 Aug 25;7(1):9448. doi: 10.1038/s41598-017-10120-8.

14.

Visceral adiposity index is strongly associated with hyperuricemia independently of metabolic health and obesity phenotypes.

Dong H, Xu Y, Zhang X, Tian S.

Sci Rep. 2017 Aug 18;7(1):8822. doi: 10.1038/s41598-017-09455-z.

15.

What makes gouty inflammation so variable?

Terkeltaub R.

BMC Med. 2017 Aug 18;15(1):158. doi: 10.1186/s12916-017-0922-5. Review.

16.

Tophaceous gout causing lumbar stenosis: A case report.

Lu H, Sheng J, Dai J, Hu X.

Medicine (Baltimore). 2017 Aug;96(32):e7670. doi: 10.1097/MD.0000000000007670.

17.

Relationship between uric acid levels and risk of chronic kidney disease in a retrospective cohort of Brazilian workers.

Chini LSN, Assis LIS, Lugon JR.

Braz J Med Biol Res. 2017 Aug 7;50(9):e6048. doi: 10.1590/1414-431X20176048.

18.

Assessment of genetic polymorphisms associated with hyperuricemia or gout in the Hmong.

Roman YM, Culhane-Pera KA, Menk J, Straka RJ.

Per Med. 2016 Sep;13(5):429-440. doi: 10.2217/pme-2016-0021. Epub 2016 Aug 1.

19.

Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study.

Landgren AJ, Jacobsson LTH, Lindström U, Sandström TZS, Drivelegka P, Björkman L, Fjellstedt E, Dehlin M.

Arthritis Res Ther. 2017 Jul 24;19(1):173. doi: 10.1186/s13075-017-1376-z.

20.

Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options.

Bardin T, Richette P.

BMC Med. 2017 Jul 3;15(1):123. doi: 10.1186/s12916-017-0890-9. Review.

Supplemental Content

Support Center